An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes.
Algorithm
Continuous glucose monitoring
Hypoglycemia
Insulin-treated diabetes
isCGM
rtCGM
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
06
05
2023
accepted:
25
07
2023
medline:
2
10
2023
pubmed:
7
9
2023
entrez:
7
9
2023
Statut:
ppublish
Résumé
Continuous Glucose Monitoring (CGM) is a key tool for insulin-treated people with diabetes (PwD). CGM devices include both real-time CGM (rtCGM) and intermittently scanned CGM (isCGM), which are associated with an improvement of glucose control and less hypoglycemia in clinical trials of people with type 1 and type 2 diabetes. This is an expert position to update a previous algorithm on the most suitable choice of CGM for insulin-treated PwD in light of the recent evidence and clinical practice. We identified six different clinical scenarios, including type 1 diabetes, type 2 diabetes, pregnancy on intensive insulin therapy, regular physical exercise, new onset of diabetes, and frailty. The use of rtCGM or isCGM is suggested, on the basis of the predominant clinical issue, as suboptimal glucose control or disabling hypoglycemia, regardless of baseline HbA The present algorithm may help to select the best CGM device based on patients' clinical characteristics, needs and clinical context, offering a further opportunity of a "tailored" therapy for people with insulin-treated diabetes.
Identifiants
pubmed: 37676398
doi: 10.1007/s12020-023-03473-w
pii: 10.1007/s12020-023-03473-w
pmc: PMC10543826
doi:
Substances chimiques
Insulin
0
Blood Glucose
0
Hypoglycemic Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
215-225Informations de copyright
© 2023. The Author(s).
Références
Front Endocrinol (Lausanne). 2022 Jun 17;13:907517
pubmed: 35784525
J Diabetes Complications. 2022 Nov;36(11):108314
pubmed: 36208566
Diabetes Care. 2021 Nov;44(11):2589-2625
pubmed: 34593612
N Engl J Med. 2022 Oct 20;387(16):1477-1487
pubmed: 36198143
Diabetes Res Clin Pract. 2015 Mar;107(3):348-54
pubmed: 25638452
Lancet Diabetes Endocrinol. 2023 Feb;11(2):96-108
pubmed: 36702566
J Diabetes Sci Technol. 2017 Nov;11(6):1138-1146
pubmed: 28449590
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
Diabetes Care. 2020 Sep;43(9):2153-2160
pubmed: 32669277
JAMA. 2021 Jun 8;325(22):2262-2272
pubmed: 34077499
Diabetes Care. 2012 Jan;35(1):32-8
pubmed: 22100963
Diabetes Care. 2020 Feb;43(2):389-397
pubmed: 31843948
Diabetes Technol Ther. 2023 Jan;25(1):50-61
pubmed: 36326825
Lancet Diabetes Endocrinol. 2016 Nov;4(11):893-902
pubmed: 27641781
Diabetes Res Clin Pract. 2022 Jan;183:109172
pubmed: 34883185
Lancet. 2016 Nov 5;388(10057):2254-2263
pubmed: 27634581
JAMA. 2020 Jun 16;323(23):2388-2396
pubmed: 32543683
Diabet Med. 2022 Jan;39(1):e14703
pubmed: 34564868
Diabetes Care. 2022 Nov 1;45(11):2753-2786
pubmed: 36148880
Diabetes Care. 2023 Jan 1;46(Suppl 1):S111-S127
pubmed: 36507635
Diabetes Technol Ther. 2022 Jun;24(6):424-434
pubmed: 35294272
Diabetes Care. 2022 Mar 1;45(3):750-753
pubmed: 35018417
Diabet Med. 2018 Apr;35(4):483-490
pubmed: 29230878
Lancet. 2017 Nov 25;390(10110):2347-2359
pubmed: 28923465
Diabetes Care. 2016 Nov;39(11):2065-2079
pubmed: 27926890
Diabetes Technol Ther. 2011 Aug;13(8):819-25
pubmed: 21599515
Diabetes Care. 2020 Nov;43(11):2744-2750
pubmed: 32859607
Endocr Pract. 2021 Jun;27(6):505-537
pubmed: 34116789
Diabetes Res Clin Pract. 2020 Jul;165:108242
pubmed: 32502689
Diabetes Res Clin Pract. 2010 Oct;90(1):22-5
pubmed: 20705354
Diabetes Technol Ther. 2019 Jan;21(1):51-55
pubmed: 30620642
Diabetes Technol Ther. 2019 Jan;21(1):6-10
pubmed: 30575413
JAMA. 2021 Jun 8;325(22):2273-2284
pubmed: 34077502
Lancet. 2018 Apr 7;391(10128):1367-1377
pubmed: 29459019
Diabetes Ther. 2017 Feb;8(1):55-73
pubmed: 28000140
JAMA. 2017 Jan 24;317(4):371-378
pubmed: 28118453
Lancet Diabetes Endocrinol. 2019 Jun;7(6):462-472
pubmed: 31047902
Diabetes Care. 2017 Dec;40(12):1631-1640
pubmed: 29162583
Diabetologia. 2020 Dec;63(12):2501-2520
pubmed: 33047169
Diabetes Obes Metab. 2023 Apr;25(4):1024-1031
pubmed: 36546594
Diabetes Technol Ther. 2020 Aug;22(8):602-612
pubmed: 32522039
Diabetes Care. 2021 Jun;44(6):1368-1376
pubmed: 33879536
Diabetes Care. 2018 Aug;41(8):1600-1607
pubmed: 29661916
JAMA. 2020 Jun 16;323(23):2397-2406
pubmed: 32543682
Diabetes Technol Ther. 2019 Jul;21(7):379-384
pubmed: 31166808
Int J Environ Res Public Health. 2022 Sep 28;19(19):
pubmed: 36231598
Ann Intern Med. 2017 Sep 19;167(6):365-374
pubmed: 28828487
Diabetes Obes Metab. 2023 Jan;25(1):110-120
pubmed: 36053813
J Diabetes Complications. 2022 Mar;36(3):108106
pubmed: 35131155
Diabetes Obes Metab. 2022 May;24(5):859-867
pubmed: 34984786
J Clin Endocrinol Metab. 2023 Feb 15;108(3):529-562
pubmed: 36477488
Cells. 2022 Dec 06;11(23):
pubmed: 36497199
Diabetes Care. 2022 Mar 1;45(3):659-665
pubmed: 35076697
J Diabetes Sci Technol. 2020 Mar;14(2):204-211
pubmed: 31709808
Diabetes Care. 2020 May;43(5):1146-1156
pubmed: 32312858